NCT00332566View on ClinicalTrials.gov

Assess Immunogenicity, Reactogenicity, Safety of a Booster of GSK Biologicals DTPw-HBV/Hib Kft Compared to DTPw-HBV/Hib

PHASE3CompletedINTERVENTIONAL
Enrollment

148

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
Hepatitis BWhole Cell PertussisTetanusHaemophilus Influenzae Type bDiphtheria
Interventions
BIOLOGICAL

DTPw-HBV/Hib Kft vaccine GSK323527A

Intramuscular injection, 1 dose

BIOLOGICAL

Tritanrix™-HepB/Hiberix™

Intramuscular injection, 1 dose

Trial Locations (2)

1425

GSK Investigational Site, Capital Federal

Unknown

GSK Investigational Site, León

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY